CD93 and Alzheimer disease: Importantly, expressions of CD44, CD93, and CD163 were found to be higher in HC of patients with AD as compared to the normal controls, while they are downregulated in healthy brain aging, indicating that CD44, CD93, and CD163 might be the key therapeutic targets for healthy brain aging.